Canandaigua National Corp Abbott Laboratories Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Canandaigua National Corp holds 60,771 shares of ABT stock, worth $6.89 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

60,771

Previous 60,232 0.89%

Holding current value

$6.89 Million

Previous $5.83 Million 14.48%

% of portfolio

1.13%

Previous 1.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $51,237 - $60,109	539 Added 0.89%	60,771 $6.67 Million
Q3 2022 Oct 05, 2022	BUY	$96.76 - $112.03 $104,404 - $120,880	1,079 Added 1.82%	60,232 $5.83 Million
Q2 2022 Jul 05, 2022	SELL	$102.07 - $123.37 $1.17 Million - $1.41 Million	-11,429 Reduced 16.19%	59,153 $6.43 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $185,966 - $226,774	-1,631 Reduced 2.26%	70,582 $8.35 Million
Q4 2021 Jan 04, 2022	SELL	$115.53 - $141.46 $25,994 - $31,828	-225 Reduced 0.31%	72,213 $10.2 Million
Q3 2021 Oct 04, 2021	BUY	$116.66 - $129.06 $167,990 - $185,846	1,440 Added 2.03%	72,438 $8.56 Million
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $20,734 - $24,407	196 Added 0.28%	70,998 $8.23 Million
Q1 2021 Apr 05, 2021	SELL	$108.84 - $128.23 $978,580 - $1.15 Million	-8,991 Reduced 11.27%	70,802 $8.49 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $126,840 - $138,219	-1,208 Reduced 1.49%	79,793 $8.74 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $317,715 - $385,842	-3,467 Reduced 4.1%	81,001 $8.82 Million
Q2 2020 Jul 07, 2020	BUY	$76.57 - $98.0 $6.47 Million - $8.28 Million	84,468 New	84,468 $7.72 Million

Others Institutions Holding ABT

# of Institutions

3,164

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Abbott Laboratories Transaction History